Cargando…
Whole‐exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene
As subsets of pheochromocytomas (PCCs) lack a defined molecular etiology, we sought to characterize the mutational landscape of PCCs to identify novel gene candidates involved in disease development. A discovery cohort of 15 PCCs wild type for mutations in PCC susceptibility genes underwent whole‐ex...
Autores principales: | Juhlin, C. Christofer, Stenman, Adam, Haglund, Felix, Clark, Victoria E., Brown, Taylor C., Baranoski, Jacob, Bilguvar, Kaya, Goh, Gerald, Welander, Jenny, Svahn, Fredrika, Rubinstein, Jill C., Caramuta, Stefano, Yasuno, Katsuhito, Günel, Murat, Bäckdahl, Martin, Gimm, Oliver, Söderkvist, Peter, Prasad, Manju L., Korah, Reju, Lifton, Richard P., Carling, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755142/ https://www.ncbi.nlm.nih.gov/pubmed/26032282 http://dx.doi.org/10.1002/gcc.22267 |
Ejemplares similares
-
HRAS mutation prevalence and associated expression patterns in pheochromocytoma
por: Stenman, Adam, et al.
Publicado: (2016) -
The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas
por: Andreasson, Adam, et al.
Publicado: (2013) -
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
por: Liu, Tiantian, et al.
Publicado: (2014) -
Recurrent Amplification of the Osmotic Stress Transcription Factor NFAT5 in Adrenocortical Carcinoma
por: Brown, Taylor C, et al.
Publicado: (2020) -
TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
por: Solhusløkk Höse, Karolina, et al.
Publicado: (2023)